collected by :Jack Luxor
Pottery Barn was down 4%, and Pottery Barn Kids and Teens are both down, 5% and 8% respectively. And despite weakness with the Pottery Barn brand, there is reason to believe this stock could be a long-term market beater. Most of the products you buy at Williams-Sonoma you can only buy at Williams-Sonoma; same with West Elm. Overall profits came in higher than expected, but Williams-Sonoma is the parent company of Pottery Barn. Cross: Yeah, and they just brought in, just this week, announced a new leader for Pottery Barn.
as mentioned in
Three biotech stocks could be the least risky of all: Celgene (NASDAQ:CELG), Ligand Pharmaceuticals (NASDAQ:LGND), and Gilead Sciences (NASDAQ:GILD). There could be temporary downturns, but my view is that all three of these biotech stocks should be winners over the long run. Biotech stocks are notoriously risky investments. Still, I think the risk for Celgene, Ligand, and Gilead is more acceptable than most biotech stocks. Gilead stock has dropped more than 25% over the last 12 months.
read more visit us Markets
Pottery Barn was down 4%, and Pottery Barn Kids and Teens are both down, 5% and 8% respectively. And despite weakness with the Pottery Barn brand, there is reason to believe this stock could be a long-term market beater. Most of the products you buy at Williams-Sonoma you can only buy at Williams-Sonoma; same with West Elm. Overall profits came in higher than expected, but Williams-Sonoma is the parent company of Pottery Barn. Cross: Yeah, and they just brought in, just this week, announced a new leader for Pottery Barn.
as mentioned in
What Happened in the Stock Market Today -- The Motley Fool
The LongHorn Steakhouse franchise, meanwhile, endured a more significant traffic decline but made up for the dip through higher prices. Same-restaurant sales rose 0.9% to mark only a slight deceleration from the prior quarter's 1.7% boost. "We continued to gain market share as we outperformed industry same-restaurant sales by a considerable margin," CEO Gene Lee said. Carnival raises expectationsA fast-expanding cruise industry helped Carnival post surprisingly strong operating results for its fiscal first quarter before the market opened on Tuesday. As for individual stocks, both Darden Restaurants (NYSE:DRI) and Carnival (NYSE:CCL) attracted heavy investor interest following the companies' latest quarterly earnings reports.Three biotech stocks could be the least risky of all: Celgene (NASDAQ:CELG), Ligand Pharmaceuticals (NASDAQ:LGND), and Gilead Sciences (NASDAQ:GILD). There could be temporary downturns, but my view is that all three of these biotech stocks should be winners over the long run. Biotech stocks are notoriously risky investments. Still, I think the risk for Celgene, Ligand, and Gilead is more acceptable than most biotech stocks. Gilead stock has dropped more than 25% over the last 12 months.
read more visit us Markets
Comments
Post a Comment